GoodRx Holdings, Inc. (GDRX): who owns it and who trades it
As of Nov 16, 2026, GDRX insiders reported 14 open-market sales worth $9.7M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Francisco Partners Iv-A, L.P. (10% owner), with $5.5M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling GoodRx Holdings
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns GDRX
160 funds and institutions reported GDRX shares worth $342M at the end of Q2 2026. The largest holder is Francisco Partners Management, LP with $173M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Francisco Partners Management, LP | 60.08M | – | $173M | No change |
| Lsv Asset Management | 5.16M | – | $14.9M | +4% |
| Ameriprise Financial Inc | 4.75M | – | $13.7M | +7% |
| Vanguard Capital Management LLC | 4.09M | – | $11.8M | -4% |
| Silver Lake Group, L.L.C. | 3.53M | – | $10.2M | No change |
| Renaissance Technologies LLC | 3.25M | – | $9.3M | -0% |
| Vanguard Portfolio Management LLC | 3.21M | – | $9.2M | -5% |
| Petrus Trust Company, LTA | 3.10M | – | $8.9M | No change |
| Dimensional Fund Advisors LP | 2.56M | – | $7.4M | +4% |
| AQR Capital Management LLC | 2.33M | – | $6.7M | +29% |
| Jane Street Group, LLC | 2.31M | – | $6.7M | +257% |
| Prescott Group Capital Management, L.L.C. | 2.11M | – | $6.1M | No change |
| BlackRock, Inc. | 1.86M | – | $5.4M | -0% |
| Technology Crossover Management X, Ltd. | 1.65M | – | $4.8M | No change |
| Geode Capital Management, LLC | 1.17M | – | $3.4M | +9% |
| Northern Trust Corp | 904,290 | – | $2.6M | +38% |
| Stifel Financial Corp | 868,790 | – | $2.5M | +21% |
| Moore Capital Management, LP | 864,044 | – | $2.5M | -44% |
| Goldman Sachs Group Inc | 858,326 | – | $2.5M | -19% |
| Two Sigma Investments, LP | 742,181 | – | $2.1M | +294% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, GDRX insiders reported $0 of open-market purchases and $9.7M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 433,088 | $3.50 | $1.5M | Form 4 |
| Aug 26, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 210,378 | $3.51 | $738K | Form 4 |
| Aug 26, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 439,310 | $3.50 | $1.5M | Form 4 |
| Aug 26, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 213,401 | $3.51 | $749K | Form 4 |
| Aug 25, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 63,183 | $3.44 | $217K | Form 4 |
| Aug 25, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 64,090 | $3.44 | $220K | Form 4 |
| Aug 24, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 71,285 | $3.46 | $247K | Form 4 |
| Aug 24, 2026 | Francisco Partners Iv-A, L.P. +4 | 10% owner | Sale | 72,309 | $3.46 | $250K | Form 4 |
| Aug 21, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 136,379 | $3.50 | $477K | Form 4 |
| Aug 21, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 138,338 | $3.50 | $484K | Form 4 |
| Aug 20, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 213,844 | $3.52 | $753K | Form 4 |
| Aug 20, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 233,415 | $3.52 | $822K | Form 4 |
| Aug 19, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 237,671 | $3.53 | $839K | Form 4 |
| Aug 19, 2026 | Francisco Partners GP IV Management Ltd +4 | 10% owner | Sale | 234,304 | $3.53 | $827K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Francisco Partners Iv-A, L.P. | 10% owner | – | $5.5M | Aug 26, 2026 |
| Francisco Partners GP IV Management Ltd | 10% owner | – | $4.2M | Aug 21, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
GDRX short interest
3.57M GDRX shares are sold short. Over the last 12 reports the number of shares short went down 67%.
As of Oct 30, 2026, 3.57M GDRX shares were sold short, down 2.7% from the report before. At the average daily volume of 1.19M shares, buying them all back would take about 3.0 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.57M | – | -3% | 1.19M | 3.0 |
| Oct 15, 2026 | 3.67M | – | -12% | 871,040 | 4.2 |
| Sep 30, 2026 | 4.16M | – | -12% | 773,441 | 5.4 |
| Sep 15, 2026 | 4.73M | – | +9% | 1.06M | 4.4 |
| Aug 31, 2026 | 4.35M | – | -15% | 1.74M | 2.5 |
| Aug 14, 2026 | 5.09M | – | -13% | 2.08M | 2.4 |
| Jul 31, 2026 | 5.86M | – | -9% | 1.09M | 5.4 |
| Jul 15, 2026 | 6.46M | – | -4% | 961,755 | 6.7 |
| Jun 30, 2026 | 6.70M | – | -11% | 1.20M | 5.6 |
| Jun 15, 2026 | 7.49M | – | +4% | 1.39M | 5.4 |
| May 29, 2026 | 7.22M | – | -34% | 1.77M | 4.1 |
| May 15, 2026 | 10.89M | – | +43% | 2.17M | 5.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
GoodRx Holdings company events
GoodRx Holdings filed 13 reports on Form 8-K in the last 12 months, 9 of them about an important change (leadership, restatement, auditor). The latest was on Nov 2, 2026.
- Nov 2, 2026RestatementThe Audit and Risk Committee of the Board of Directors of GoodRx Holdings, Inc., after discussion with management of the Company and the Company’s independent registered public accounting firm, KPMG LLP, concluded that the Company’s condensed consolidated financial statements for the fiscal quarter… Filing
- Aug 5, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
- Aug 5, 2026ResultsReleased financial results. Filing
- Jun 18, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Apr 24, 2026LeadershipThe Board of Directors of GoodRx Holdings, Inc. appointed Thomas Chan, Vice President, Corporate Controller of the Company as the Company’s Chief Accounting Officer and designated Mr. Chan as the principal accounting officer of the Company, in each case effective immediately. Filing
- Apr 3, 2026LeadershipIan T. Clark notified GoodRx Holdings, Inc. of his decision to resign as a member of the Company’s Board of Directors (the “Board“), including his service on the Board’s Nominating & Governance Committee, effective as of March 31, 2026. Filing
- Mar 27, 2026LeadershipRomin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, Inc., effective April 3, 2026 in order to pursue other opportunities. Filing
- Mar 18, 2026AuditorThe Audit and Risk Committee of the Board of Directors of GoodRx Holdings, Inc., following a competitive proposal process, approved the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the dismissal of… Filing
- Mar 6, 2026LeadershipThe Board of Directors of GoodRx Holdings, Inc., upon the recommendation of the Compensation Committee of the Board approved a discretionary cash bonus for 2025 performance in the amount of $72,918 for Romin Nabiey, the Company’s Chief Accounting Officer. Filing
- Feb 27, 2026LeadershipDipanjan Deb notified GoodRx Holdings, Inc. of his decision to resign as a member of the Company’s Board of Directors, effective as of February 26, 2026. Filing
- Feb 25, 2026ResultsReleased financial results. Filing
- Dec 12, 2025LeadershipThe Board of Directors of GoodRx Holdings, Inc. approved the entry by GoodRx, Inc. (a subsidiary of the Company) into retention bonus letter agreements with each of Wendy Barnes, Chief Executive Officer and President of the Company, and Chris McGinnis, Chief Financial Officer and Treasurer of the… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
GoodRx Holdings financials
Famous investors that hold GDRX
4 of the 50 well-known investors we track reported holding GDRX in their latest 13F filing. The largest position is Jim Simons's, worth $10.6M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 3.22M | $10.6M | 0.0% | -1% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 133,508 | $439K | 0.0% | +28% |
| Israel Englander · Millennium Management | Q3 2026 | 100,018 | $329K | 0.0% | -72% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 74,085 | $244K | 0.0% | +283% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named GDRX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 10, 2026 | LSV ASSET MANAGEMENT | 13G | 5.5% |
| Nov 10, 2026 | LSV ASSET MANAGEMENT | 13G | 5.5% |
Questions about GoodRx Holdings, Inc. (GDRX) stock
Who owns the most GDRX stock?
The largest reported owner of GoodRx Holdings, Inc. (GDRX) is Francisco Partners Management, LP. In total, 160 funds and institutions reported holding GDRX at the end of Q2 2026. See the largest owners.
Are GDRX insiders buying or selling?
In the last 12 months, GDRX insiders reported no open-market purchases and 14 sales worth $9.7M. The latest trade was on Aug 26, 2026. See every trade.
What is the short interest in GDRX?
As of Oct 30, 2026, 3.57M GDRX shares were sold short, down 2.7% from the report before. At the average daily volume of 1.19M shares, buying them all back would take about 3.0 trading days (days to cover). See the history.
Which famous investors hold GDRX?
4 of the 50 well-known investors we track reported GDRX in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $10.6M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.